NeuronesXPAR:NRO -0.28%96 FCF Margin % is 13.58% as of Dec. 2025, which is 89% above its 10-year median of 7.20. GuruFocus rates XPAR:NRO with a GF Score™ of 96/100 and a GF Value™ of €50.23 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 2,814 Software companies, Neurones ranks better than 63.22% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Neurones's Free Cash Flow for the
six
months ended in Dec. 2025 was €58.8 Mil. Neurones's Revenue for the
six
months ended in Dec. 2025 was €432.9 Mil. Therefore, Neurones's FCF Margin % for the quarter that ended in Dec. 2025 was 13.58%.
The historical rank and industry rank for Neurones's FCF Margin % or its related term are showing as below:
XPAR:NRO'
s FCF Margin % Range Over the Past 10 Years
Min: 2.95 Med: 7.2 Max: 11.46
Current: 7.1
During the past 13 years, the highest FCF Margin % of Neurones was 11.46%. The lowest was 2.95%. And the median was 7.20%.
XPAR:NRO's FCF Margin % is ranked better than 63.22% of 2814
companies
in the Software industry
Industry Median: 2.41
vs XPAR:NRO: 7.10
Neurones FCF Margin % Related Terms
Neurones FCF Margin % Historical Data
* Premium members only.
The historical data trend for Neurones's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:NRO vs IBM, ACN, FISV: FCF Margin % Comparison
For the Information Technology Services subindustry, Neurones's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurones FCF Margin % vs Software Industry
For the Software industry and Technology sector, Neurones's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Neurones's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurones (XPAR:NRO) has a FCF Margin % of 13.58% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Neurones and its competitors. This is 89% above median its historical median of 7.20. Over the past decade, Neurones' FCF Margin % has ranged from 2.95 to 11.46. According to the industry distribution chart, Neurones ranks #1035 out of 2814 companies in the Software industry, placing it in the top 36.8%.
Is Neurones' FCF Margin % too high?
Neurones' current FCF Margin % of 13.58% is 89% above median its 10-year median of 7.20. Over the past 10 years, this metric has ranged from a low of 2.95 to a high of 11.46. The Software industry median FCF Margin % is 2.41. Neurones' value of 13.58% is 463.5% above this industry median. Based on the distribution chart, Neurones ranks #1035 out of 2814 companies in the Software industry, which is above the industry midpoint. Overall, Neurones has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' FCF Margin % compare to IBM and ACN?
According to the Software industry distribution chart, Neurones ranks #1035 out of 2814 companies for FCF Margin %. This puts Neurones in the upper half of its industry. The industry median FCF Margin % is 2.41. Neurones' value of 13.58% is 463.5% above this benchmark. Historically, Neurones' own FCF Margin % has ranged from 2.95 to 11.46 over the past decade. While the company's 10-year median is 7.20 vs. the industry median of 2.41, Neurones has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Software company?
The median FCF Margin % among Software companies is 2.41, based on 2,814 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neurones's current FCF Margin % of 13.58% is 463.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Neurones and its competitors. For the Software industry, the median FCF Margin % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurones's current FCF Margin % is 13.58%, which is 89% above median its own 10-year median of 7.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Significantly Undervalued. The stock's GF Value™ is €50.23, compared to a current price of €35.10 — trading 30.1% below its estimated fair value. The current FCF Margin % is 13.58%, which is 89% above median its 10-year median of 7.20 and 463.5% above the Software industry median of 2.41. Neurones' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current FCF Margin % is 13.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurones (XPAR:NRO) Overvalued in 2026?
Based on GuruFocus' analysis, Neurones stock appears to be undervalued.
The current stock price of €35.10 is trading 30.1% below its estimated GF Value™ of €50.23.
GuruFocus considers Neurones to be Significantly Undervalued.
Key valuation signals for XPAR:NRO:
FCF Margin %: 13.58% (89% above median its 10-year median of 7.20)
GF Value™: €50.23 vs. price of €35.10 (30.1% below fair value)
Industry Position: 463.5% above the Software median (#1035 of 2814)
No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
96GF Score
Get the complete analysis for XPAR:NRO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:NRO has been successfully added to your 
